The impact of active smoking on survival outcome in metastatic renal cell carcinoma patients treated with targeted therapy.Haoran Li, Daniel Yick Chin Heng, Hao‐Wen Sim et al.|Journal of Clinical Oncology|2016Cited by 1
Refining intermediate-risk (IR) stratification in patients (Pts) with metastatic renal cell carcinoma (mRCC) receiving first-line (1L) immunotherapy (IO) within one year of diagnosis (Dx): Findings from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).Razane El Hajj Chehade, Toni K. Choueiri, Rashad Nawfal et al.|Journal of Clinical Oncology|2025Cited by 0